Bone Biologics (BBLG) EPS (Diluted) (2015 - 2026)
Powered by 
Analysis
Bone Biologics (BBLG) EPS (Diluted) (2015 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.52 Bn | 133.66 Bn | 2.84 Bn | 4.31 |
| 2 | Regeneron Pharmaceuticals | 86.69 Bn | 78.69 Bn | 3.93 Bn | 12.23 |
| 3 | Argenx Se | 64.63 Bn | 59.45 Bn | 1.37 Bn | 7.15 |
| 4 | Moderna | 59.30 Bn | 54.16 Bn | 52.00 Mn | -1.96 |
| 5 | Revolution Medicines | 44.41 Bn | 44.41 Bn | - | -3.06 |
| 6 | BeOne Medicines | 40.45 Bn | 35.35 Bn | 1.53 Bn | 2.05 |
| 7 | Alnylam Pharmaceuticals | 35.29 Bn | 31.98 Bn | 992.69 Mn | 1.19 |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | 0.15 |
| 9 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn | -0.06 |
| 10 | Bone Biologics | 1.00 Mn | 1.00 Mn | - | -0.43 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -0.43 |
| Dec 31, 2025 | -0.58 |
| Sep 30, 2025 | -0.37 |
| Jun 30, 2025 | -1.33 |
| Mar 31, 2025 | -1.92 |
| Dec 31, 2024 | -6.02 |
| Sep 30, 2024 | -14.21 |
| Jun 30, 2024 | -4.08 |
| Mar 31, 2024 | -8.20 |
| Dec 31, 2023 | -35.34 |
| Sep 30, 2023 | -29.40 |
| Jun 30, 2023 | -139.34 |
| Mar 31, 2023 | -280.98 |
| Dec 31, 2022 | -162.04 |
| Sep 30, 2022 | -169.63 |
| Jun 30, 2022 | -60.91 |
| Mar 31, 2022 | -18.71 |
| Dec 31, 2021 | -4.78 |
| Sep 30, 2021 | -13.82 |
| Jun 30, 2021 | -13.35 |